FLUOROMETHOLONE ACETATE

FLUOROMETHOLONE ACETATE was reported 267 times

FLUOROMETHOLONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OSTEOFIBROMA 1 0.1429
1 OCCUPATIONAL PROBLEM ENVIRONMENTAL 2 0.0339
2 VITAL DYE STAINING CORNEA PRESENT 1 0.0294
3 CORNEAL EPITHELIUM DISORDER 1 0.0286
4 URTICARIA AQUAGENIC 1 0.0286
5 CORNEAL STRIAE 1 0.0141
6 GRIP STRENGTH 3 0.0131
7 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
8 CORNEAL THINNING 3 0.0117
9 URTICARIA CHOLINERGIC 1 0.0105
10 CORNEAL OPERATION 1 0.0097
11 LACRIMATION DISORDER 1 0.0082
12 SWOLLEN JOINT COUNT 2 0.0080
13 INFLAMMATORY MYOFIBROBLASTIC TUMOUR 1 0.0077
14 CORNEAL DEFECT 1 0.0076
15 CONJUNCTIVAL SCAR 1 0.0066
16 FACIAL OPERATION 1 0.0062
17 PERIORBITAL PAIN 5 0.0059
18 ABDOMINAL HERNIA REPAIR 1 0.0054
19 ANTIPHOSPHOLIPID ANTIBODIES 1 0.0051
20 INTRAOCULAR PRESSURE FLUCTUATION 1 0.0051
21 CATARACT SUBCAPSULAR 3 0.0049
22 KERATITIS FUNGAL 1 0.0048
23 POST PROCEDURAL HYPOTHYROIDISM 1 0.0047
24 CORNEAL OPACITY 6 0.0044
25 ENDOTHELIAL DYSFUNCTION 1 0.0043
26 EUSTACHIAN TUBE DISORDER 1 0.0042
27 CORNEAL DEGENERATION 1 0.0041
28 ANAEMIA VITAMIN B12 DEFICIENCY 2 0.0040
29 BURNING FEET SYNDROME 1 0.0040
30 SKIN DESQUAMATION 1 0.0040
31 GINGIVAL EROSION 1 0.0039
32 SCLERAL DISORDER 1 0.0037
33 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
34 IMPAIRED FASTING GLUCOSE 1 0.0033
35 CORNEAL INFILTRATES 1 0.0032
36 KERATOPATHY 5 0.0032
37 RIGHT VENTRICULAR ENLARGEMENT 1 0.0031
38 CONJUNCTIVITIS BACTERIAL 1 0.0029
39 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
40 ANION GAP DECREASED 1 0.0029
41 ARACHNOID CYST 1 0.0025
42 LUPUS VULGARIS 3 0.0024
43 EXPOSURE VIA EYE CONTACT 1 0.0024
44 ANTI-THYROID ANTIBODY POSITIVE 1 0.0022
45 C-REACTIVE PROTEIN 2 0.0022
46 PORPHYRIA ACUTE 3 0.0021
47 HYPOHIDROSIS 1 0.0020
48 GLARE 1 0.0019
49 URTICARIAL VASCULITIS 1 0.0019
50 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
51 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 1 0.0018
52 RETINITIS 3 0.0017
53 CORNEAL EPITHELIUM DEFECT 1 0.0017
54 X-RAY ABNORMAL 3 0.0017
55 PUPILLARY DISORDER 1 0.0016
56 BLOOD CORTISOL DECREASED 1 0.0016
57 CATARACT NUCLEAR 1 0.0015
58 DEEP VEIN THROMBOSIS POSTOPERATIVE 3 0.0015
59 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 1 0.0015
60 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 3 0.0014
61 CUSHING'S SYNDROME 1 0.0014
62 OPTIC NEUROPATHY 3 0.0014
63 MONOCYTE PERCENTAGE INCREASED 1 0.0014
64 CORNEAL DISORDER 3 0.0014
65 FOREIGN BODY TRAUMA 1 0.0014
66 CORNEAL OEDEMA 3 0.0013
67 BASOPHIL COUNT INCREASED 1 0.0013
68 DISLOCATION OF VERTEBRA 3 0.0013
69 PRODUCT KNOWLEDGE DEFICIT 1 0.0013
70 CORNEAL TRANSPLANT 1 0.0013
71 PRODUCT DROPPER ISSUE 1 0.0013
72 VITAMIN B12 INCREASED 1 0.0013
73 INCORRECT DOSE ADMINISTERED BY PRODUCT 2 0.0012
74 ENDOCRINE OPHTHALMOPATHY 1 0.0012
75 EYE PAIN 64 0.0011
76 PRODUCT DELIVERY MECHANISM ISSUE 6 0.0011
77 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
78 OCULAR HYPERTENSION 2 0.0010
79 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
80 EYELID PAIN 2 0.0010
81 SWOLLEN JOINT COUNT INCREASED 3 0.0009
82 FACET JOINT SYNDROME 3 0.0009
83 HALO VISION 1 0.0009
84 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
85 MORBID THOUGHTS 1 0.0009
86 PHOTOPHOBIA 16 0.0008
87 BONE EROSION 3 0.0008
88 CONJUNCTIVAL HYPERAEMIA 3 0.0008
89 PHARYNGEAL HAEMORRHAGE 1 0.0008
90 INSTILLATION SITE PAIN 2 0.0008
91 OCULAR DISCOMFORT 9 0.0008
92 INTRAOCULAR PRESSURE INCREASED 10 0.0008
93 IATROGENIC INJURY 1 0.0008
94 PERIPHERAL VENOUS DISEASE 3 0.0007
95 CARBON DIOXIDE INCREASED 1 0.0007
96 CORNEAL ABRASION 1 0.0007
97 ASTHENOPIA 4 0.0007
98 DEATH NEONATAL 1 0.0007
99 DRUG TOLERANCE DECREASED 2 0.0007
100 PERIORBITAL SWELLING 4 0.0007
101 AUDITORY DISORDER 1 0.0007
102 PRODUCT DISPENSING ISSUE 3 0.0007
103 EYELID MARGIN CRUSTING 2 0.0007
104 THORACIC VERTEBRAL FRACTURE 2 0.0007
105 EYE DISCHARGE 7 0.0007
106 RHEUMATIC FEVER 3 0.0007
107 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
108 EYE OPERATION 3 0.0007
109 ORAL MUCOSAL ERYTHEMA 1 0.0006
110 FOREIGN BODY SENSATION IN EYES 4 0.0006
111 SPINAL CORD DISORDER 1 0.0006
112 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
113 SPINAL DEFORMITY 1 0.0006
114 TREATMENT DELAYED 1 0.0006
115 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
116 VERTIGO POSITIONAL 1 0.0006
117 AORTIC VALVE STENOSIS 1 0.0006
118 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
119 ERYTHEMA OF EYELID 3 0.0006
120 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
121 LIP DISORDER 1 0.0005
122 MYELOPATHY 1 0.0005
123 ARTERIAL DISORDER 1 0.0005
124 RETINAL OEDEMA 1 0.0005
125 EYE IRRITATION 30 0.0005
126 RHEUMATOID FACTOR POSITIVE 3 0.0005
127 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
128 BLEPHARITIS 2 0.0005
129 EYE CONTUSION 1 0.0005
130 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
131 BREAST CANCER STAGE III 3 0.0005
132 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
133 BLOOD LOSS ANAEMIA 1 0.0004
134 PERIARTHRITIS 1 0.0004
135 ESCHERICHIA BACTERAEMIA 1 0.0004
136 EYE INFLAMMATION 4 0.0004
137 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3 0.0004
138 HYPERCHOLESTEROLAEMIA 4 0.0004
139 RETINAL TEAR 1 0.0004
140 DUODENAL ULCER PERFORATION 3 0.0004
141 EYELID IRRITATION 1 0.0004
142 MEDICATION RESIDUE 1 0.0004
143 BLOOD CHLORIDE DECREASED 1 0.0004
144 OCULAR HYPERAEMIA 18 0.0004
145 PROTEIN TOTAL INCREASED 1 0.0004
146 WOUND INFECTION 4 0.0004
147 MUSCLE INJURY 3 0.0004
148 LIVE BIRTH 3 0.0004
149 SENSATION OF FOREIGN BODY 3 0.0004
150 BREAST CANCER STAGE IV 1 0.0004
151 PRODUCT CONTAINER ISSUE 3 0.0003
152 GRIP STRENGTH DECREASED 3 0.0003
153 GROWTH RETARDATION 1 0.0003
154 THYROIDITIS 1 0.0003
155 LACRIMATION INCREASED 10 0.0003
156 LUPUS-LIKE SYNDROME 3 0.0003
157 LIP DRY 3 0.0003
158 EYE INJURY 1 0.0003
159 KERATITIS 1 0.0003
160 EXOSTOSIS 3 0.0003
161 SWELLING OF EYELID 2 0.0003
162 BLEPHAROSPASM 2 0.0003
163 PRODUCT USE COMPLAINT 5 0.0003
164 PHOTOPSIA 2 0.0003
165 BLADDER PAIN 1 0.0003
166 LOOSE TOOTH 1 0.0003
167 AUTOIMMUNE DISORDER 3 0.0003
168 DEAFNESS NEUROSENSORY 1 0.0003
169 WALKING AID USER 2 0.0003
170 SINUS CONGESTION 4 0.0003
171 HELICOBACTER INFECTION 3 0.0003
172 PUSTULAR PSORIASIS 1 0.0003
173 LEFT VENTRICULAR FAILURE 1 0.0003
174 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
175 GRANULOMA 1 0.0003
176 DEPRESSION SUICIDAL 1 0.0003
177 FOLLICULITIS 3 0.0003
178 SPONDYLITIS 1 0.0003
179 FOOT DEFORMITY 3 0.0003
180 PROTEIN TOTAL DECREASED 1 0.0003
181 POST PROCEDURAL COMPLICATION 5 0.0003
182 FAECES HARD 1 0.0003
183 SPINAL CORD COMPRESSION 1 0.0003
184 PNEUMONIA FUNGAL 1 0.0003
185 SCIATICA 4 0.0003
186 PRODUCT ADMINISTRATION ERROR 5 0.0002
187 BURSITIS 3 0.0002
188 SPINAL FUSION SURGERY 1 0.0002
189 DEMYELINATION 1 0.0002
190 VISUAL ACUITY REDUCED 8 0.0002
191 PEMPHIGUS 3 0.0002
192 HORDEOLUM 1 0.0002
193 HAND DEFORMITY 3 0.0002
194 DIVERTICULUM INTESTINAL 1 0.0002
195 JOINT RANGE OF MOTION DECREASED 3 0.0002
196 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
197 IRON DEFICIENCY ANAEMIA 2 0.0002
198 EYE DISORDER 7 0.0002
199 SUBCUTANEOUS ABSCESS 1 0.0002
200 RASH VESICULAR 1 0.0002
201 EAR PAIN 4 0.0002
202 VITAMIN D DEFICIENCY 2 0.0002
203 PHARYNGEAL SWELLING 2 0.0002
204 PANCREATIC DISORDER 1 0.0002
205 PRESCRIBED UNDERDOSE 4 0.0002
206 PATHOLOGICAL FRACTURE 1 0.0002
207 VARICOSE VEIN 1 0.0002
208 THERAPY PARTIAL RESPONDER 3 0.0002
209 WEIGHT FLUCTUATION 2 0.0002
210 PARTIAL SEIZURES 1 0.0002
211 OBESITY 3 0.0002
212 EYE SWELLING 7 0.0002
213 GINGIVITIS 1 0.0002
214 BEHAVIOUR DISORDER 1 0.0002
215 NORMAL NEWBORN 1 0.0002
216 OESOPHAGITIS 2 0.0002
217 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
218 DRY EYE 9 0.0002
219 PERICARDITIS 3 0.0002
220 EYE INFECTION 2 0.0002
221 DERMATITIS CONTACT 2 0.0002
222 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
223 EYELID OEDEMA 2 0.0002
224 URINE ODOUR ABNORMAL 1 0.0002
225 POLYNEUROPATHY 2 0.0002
226 SYNOVITIS 3 0.0002
227 INGUINAL HERNIA 1 0.0002
228 HEPATIC CIRRHOSIS 3 0.0002
229 LOWER LIMB FRACTURE 3 0.0002
230 GLAUCOMA 3 0.0002
231 PRESCRIBED OVERDOSE 3 0.0002
232 INFLAMMATION 8 0.0002
233 VISION BLURRED 21 0.0002
234 CORONAVIRUS INFECTION 1 0.0002
235 FULL BLOOD COUNT DECREASED 3 0.0001
236 ULCER HAEMORRHAGE 1 0.0001
237 UVEITIS 2 0.0001
238 LYMPHOEDEMA 1 0.0001
239 LARGE INTESTINE PERFORATION 1 0.0001
240 WOUND 4 0.0001
241 BLINDNESS UNILATERAL 2 0.0001
242 THERMAL BURN 1 0.0001
243 BRONCHOSPASM 2 0.0001
244 PRODUCT SUPPLY ISSUE 1 0.0001
245 IRRITABLE BOWEL SYNDROME 3 0.0001
246 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
247 MAJOR DEPRESSION 1 0.0001
248 GLOSSODYNIA 3 0.0001
249 SNEEZING 3 0.0001
250 GENERAL SYMPTOM 1 0.0001
251 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
252 AORTIC ANEURYSM 1 0.0001
253 HAEMODYNAMIC INSTABILITY 1 0.0001
254 HIP ARTHROPLASTY 2 0.0001
255 PROCEDURAL COMPLICATION 1 0.0001
256 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
257 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
258 FURUNCLE 1 0.0001
259 NASAL DISCOMFORT 1 0.0001
260 RHINITIS 1 0.0001
261 MUSCLE TIGHTNESS 2 0.0001
262 FIBROMYALGIA 3 0.0001
263 BLINDNESS 5 0.0001
264 LIVER INJURY 3 0.0001
265 IMPAIRED HEALING 4 0.0001
266 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
267 PHOTOSENSITIVITY REACTION 2 0.0001
268 SPINAL COMPRESSION FRACTURE 1 0.0001
269 SECOND PRIMARY MALIGNANCY 1 0.0001
270 BREAST CANCER STAGE II 1 0.0001
271 ROAD TRAFFIC ACCIDENT 5 0.0001
272 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
273 FACIAL PARALYSIS 1 0.0001
274 CARDIAC MURMUR 1 0.0001
275 NAIL DISORDER 1 0.0001
276 EAR INFECTION 3 0.0001
277 MYOSITIS 1 0.0001
278 FREQUENT BOWEL MOVEMENTS 3 0.0001
279 ACCIDENTAL OVERDOSE 4 0.0001
280 RETINAL DETACHMENT 1 0.0001
281 CONJUNCTIVITIS 2 0.0001
282 NEPHROPATHY 1 0.0001
283 ARTERIOSCLEROSIS 1 0.0001
284 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
285 PULMONARY FIBROSIS 2 0.0001
286 VITREOUS FLOATERS 1 0.0001
287 LABORATORY TEST ABNORMAL 3 0.0001
288 BODY TEMPERATURE DECREASED 1 0.0001
289 HOSPICE CARE 1 0.0001
290 DISABILITY 2 0.0001
291 RESPIRATORY DISORDER 3 0.0001
292 OVARIAN CYST 1 0.0001
293 PREGNANCY 2 0.0001
294 TASTE DISORDER 2 0.0001
295 PSORIATIC ARTHROPATHY 4 0.0001
296 DRY THROAT 1 0.0001
297 TOOTH ABSCESS 1 0.0001
298 KNEE ARTHROPLASTY 2 0.0001
299 JOINT DISLOCATION 1 0.0001
300 RENAL PAIN 1 0.0001
301 BODY HEIGHT DECREASED 1 0.0001
302 BREAST CANCER METASTATIC 1 0.0001
303 NIGHT SWEATS 3 0.0001
304 PHARYNGITIS STREPTOCOCCAL 1 0.0001
305 SKIN LACERATION 1 0.0001
306 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
307 TYPE 2 DIABETES MELLITUS 3 0.0001
308 INTESTINAL PERFORATION 1 0.0001
309 IMPAIRED DRIVING ABILITY 1 0.0001
310 GASTRIC HAEMORRHAGE 1 0.0001
311 DELIRIUM 3 0.0001
312 MADAROSIS 1 0.0001
313 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
314 HYPERLIPIDAEMIA 1 0.0001
315 C-REACTIVE PROTEIN INCREASED 3 0.0001
316 NO THERAPEUTIC RESPONSE 1 0.0001
317 DISCOMFORT 5 0.0001
318 CYTOPENIA 1 0.0001
319 MUSCLE SPASTICITY 1 0.0001
320 CARDIOMEGALY 1 0.0001
321 SPINAL OPERATION 1 0.0001
322 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
323 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
324 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
325 JOINT STIFFNESS 2 0.0001
326 EYE HAEMORRHAGE 1 0.0001
327 QUALITY OF LIFE DECREASED 1 0.0001
328 DRY MOUTH 6 0.0001
329 GINGIVAL BLEEDING 1 0.0001
330 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
331 VISUAL IMPAIRMENT 9 0.0001
332 ORAL DISCOMFORT 1 0.0001
333 CARPAL TUNNEL SYNDROME 1 0.0001
334 OSTEOARTHRITIS 3 0.0001
335 INTENTIONAL DOSE OMISSION 2 0.0001
336 RECTAL HAEMORRHAGE 3 0.0001
337 IMPAIRED QUALITY OF LIFE 1 0.0001
338 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
339 APATHY 1 0.0001
340 INTENTIONAL PRODUCT MISUSE 6 0.0001
341 SINUSITIS 7 0.0001
342 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
343 LIVER DISORDER 3 0.0001
344 CATARACT 4 0.0001
345 COLITIS ULCERATIVE 3 0.0001
346 COLON CANCER 1 0.0001
347 THROAT IRRITATION 3 0.0001
348 THERAPY NON-RESPONDER 3 0.0001
349 BONE LOSS 1 0.0001
350 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
351 BLOOD COUNT ABNORMAL 1 0.0001
352 OSTEOPENIA 1 0.0001
353 ILL-DEFINED DISORDER 4 0.0001
354 EPILEPSY 2 0.0001
355 FEELING HOT 4 0.0001
356 PRODUCT DOSE OMISSION ISSUE 19 0.0001
357 BLOOD CHOLESTEROL INCREASED 3 0.0001
358 ACUTE MYELOID LEUKAEMIA 1 0.0001
359 SWOLLEN TONGUE 2 0.0001
360 BACK DISORDER 1 0.0001
361 LUNG DISORDER 3 0.0001
362 VENTRICULAR TACHYCARDIA 1 0.0001
363 GAIT INABILITY 2 0.0001
364 EYE PRURITUS 2 0.0001
365 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
366 HEPATIC ENZYME INCREASED 4 0.0001
367 MULTI-ORGAN FAILURE 1 0.0001
368 DEVICE DEFECTIVE 1 0.0001
369 MUSCULOSKELETAL PAIN 3 0.0001
370 DEVICE USE ISSUE 1 0.0001
371 SLEEP DISORDER 4 0.0001
372 LYMPHOCYTE COUNT DECREASED 1 0.0001
373 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
374 GOUT 1 0.0001
375 GASTROENTERITIS VIRAL 1 0.0001
376 OEDEMA 3 0.0001
377 TOOTHACHE 1 0.0001
378 OSTEOMYELITIS 1 0.0001
379 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
380 ARTHROPATHY 3 0.0001
381 MEDICATION ERROR 3 0.0001
382 AGRANULOCYTOSIS 1 0.0001
383 HEPATIC STEATOSIS 1 0.0001
384 BLISTER 3 0.0001
385 BLOOD SODIUM DECREASED 1 0.0001
386 MUSCULAR WEAKNESS 6 0.0001
387 FOOT FRACTURE 1 0.0001
388 CONTUSION 5 0.0001
389 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
390 WHEEZING 3 0.0001
391 STOMATITIS 3 0.0000
392 VERTIGO 3 0.0000
393 NEUTROPHIL COUNT DECREASED 2 0.0000
394 BODY TEMPERATURE INCREASED 1 0.0000
395 OSTEOPOROSIS 2 0.0000
396 TREATMENT FAILURE 4 0.0000
397 TOOTH LOSS 1 0.0000
398 PULMONARY HYPERTENSION 1 0.0000
399 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
400 URTICARIA 8 0.0000
401 DERMATITIS 1 0.0000
402 MOUTH ULCERATION 1 0.0000
403 BALANCE DISORDER 4 0.0000
404 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
405 AMNESIA 3 0.0000
406 SEPTIC SHOCK 2 0.0000
407 PRODUCT DISPENSING ERROR 1 0.0000
408 MUSCULOSKELETAL STIFFNESS 4 0.0000
409 APPLICATION SITE PAIN 1 0.0000
410 INFUSION RELATED REACTION 3 0.0000
411 FEBRILE NEUTROPENIA 3 0.0000
412 STEVENS-JOHNSON SYNDROME 1 0.0000
413 HEPATOTOXICITY 1 0.0000
414 PRODUCT AVAILABILITY ISSUE 1 0.0000
415 SKIN IRRITATION 2 0.0000
416 HYPOKALAEMIA 2 0.0000
417 SWELLING 4 0.0000
418 INJURY 3 0.0000
419 THERAPY INTERRUPTED 3 0.0000
420 PRODUCTIVE COUGH 2 0.0000
421 MOBILITY DECREASED 3 0.0000
422 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
423 DIABETIC KETOACIDOSIS 1 0.0000
424 DRUG INTOLERANCE 4 0.0000
425 NEURALGIA 1 0.0000
426 UNDERDOSE 3 0.0000
427 OEDEMA PERIPHERAL 5 0.0000
428 BRONCHITIS 3 0.0000
429 OSTEONECROSIS OF JAW 1 0.0000
430 PRODUCT COMPLAINT 1 0.0000
431 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
432 EXPOSURE VIA SKIN CONTACT 1 0.0000
433 RESPIRATORY TRACT INFECTION 1 0.0000
434 MUCOSAL INFLAMMATION 1 0.0000
435 ARTHRITIS 3 0.0000
436 PARAESTHESIA 6 0.0000
437 PANCREATITIS 2 0.0000
438 HYPERSENSITIVITY 7 0.0000
439 RASH PRURITIC 2 0.0000
440 MEMORY IMPAIRMENT 5 0.0000
441 NECK PAIN 2 0.0000
442 ASTHMA 4 0.0000
443 RED BLOOD CELL COUNT DECREASED 1 0.0000
444 HYPERSOMNIA 1 0.0000
445 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
446 LIVER FUNCTION TEST ABNORMAL 1 0.0000
447 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
448 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
449 ASCITES 1 0.0000
450 RENAL INJURY 1 0.0000
451 GASTROINTESTINAL DISORDER 3 0.0000
452 HYPOAESTHESIA 5 0.0000
453 THERAPEUTIC RESPONSE DECREASED 2 0.0000
454 SUICIDE ATTEMPT 2 0.0000
455 ADVERSE EVENT 3 0.0000
456 PRODUCT USE ISSUE 6 0.0000
457 DRUG-INDUCED LIVER INJURY 1 0.0000
458 DEEP VEIN THROMBOSIS 2 0.0000
459 DYSPEPSIA 3 0.0000
460 HEADACHE 19 0.0000
461 URINARY RETENTION 1 0.0000
462 ABDOMINAL DISCOMFORT 5 0.0000
463 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
464 HAEMATURIA 1 0.0000
465 NEOPLASM PROGRESSION 1 0.0000
466 BURNING SENSATION 2 0.0000
467 LYMPHADENOPATHY 1 0.0000
468 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
469 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
470 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
471 PANIC ATTACK 1 0.0000
472 MUSCLE SPASMS 5 0.0000
473 CHEST PAIN 5 0.0000
474 DYSARTHRIA 1 0.0000
475 RHEUMATOID ARTHRITIS 3 0.0000
476 DEPRESSION 6 0.0000
477 CHRONIC KIDNEY DISEASE 2 0.0000
478 GAIT DISTURBANCE 5 0.0000
479 PERIPHERAL SWELLING 4 0.0000
480 PLASMA CELL MYELOMA 1 0.0000
481 PALPITATIONS 3 0.0000
482 JOINT SWELLING 3 0.0000
483 EMOTIONAL DISTRESS 3 0.0000
484 CONFUSIONAL STATE 4 0.0000
485 DIZZINESS 12 0.0000
486 ASTHENIA 9 0.0000
487 HYPERTENSION 5 0.0000
488 CONDITION AGGRAVATED 7 0.0000
489 COVID-19 4 0.0000
490 ANGIOEDEMA 1 0.0000
491 INSOMNIA 6 0.0000
492 WEIGHT INCREASED 5 0.0000
493 ADVERSE DRUG REACTION 2 0.0000
494 NEPHROLITHIASIS 1 0.0000
495 TINNITUS 1 0.0000
496 SKIN DISCOLOURATION 1 0.0000
497 NASOPHARYNGITIS 4 0.0000
498 OFF LABEL USE 19 0.0000
499 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
500 PNEUMONIA 7 0.0000
501 WEIGHT DECREASED 6 0.0000
502 COGNITIVE DISORDER 1 0.0000
503 CARDIAC DISORDER 2 0.0000
504 ARRHYTHMIA 1 0.0000
505 PULMONARY EMBOLISM 2 0.0000
506 MIGRAINE 2 0.0000
507 RASH ERYTHEMATOUS 1 0.0000
508 INFECTION 3 0.0000
509 LEUKOPENIA 1 0.0000
510 CELLULITIS 1 0.0000
511 FLUSHING 2 0.0000
512 FLUID RETENTION 1 0.0000
513 ILLNESS 2 0.0000
514 FATIGUE 15 0.0000
515 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
516 NERVOUSNESS 1 0.0000
517 ECZEMA 1 0.0000
518 DERMATITIS ATOPIC 1 0.0000
519 DEPRESSED MOOD 1 0.0000
520 BRADYCARDIA 1 0.0000
521 PLATELET COUNT DECREASED 2 0.0000
522 TREATMENT NONCOMPLIANCE 1 0.0000
523 MALAISE 8 0.0000
524 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
525 PAIN 11 0.0000
526 FLATULENCE 1 0.0000
527 ANXIETY 5 0.0000
528 BACK PAIN 4 0.0000
529 BONE PAIN 1 0.0000
530 DIARRHOEA 11 0.0000
531 NASAL CONGESTION 1 0.0000
532 DRUG INEFFECTIVE 22 0.0000
533 PLEURAL EFFUSION 1 0.0000
534 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
535 EXPOSURE DURING PREGNANCY 1 0.0000
536 RHINORRHOEA 1 0.0000
537 SWELLING FACE 1 0.0000
538 PRODUCT DOSE OMISSION 1 0.0000
539 PSORIASIS 2 0.0000
540 ALOPECIA 3 0.0000
541 FALL 5 0.0000
542 DRY SKIN 2 0.0000
543 SOMNOLENCE 3 0.0000
544 ABDOMINAL PAIN UPPER 3 0.0000
545 PYREXIA 5 0.0000
546 COUGH 4 0.0000
547 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
548 PAIN IN EXTREMITY 4 0.0000
549 HOT FLUSH 1 0.0000
550 BLOOD PRESSURE INCREASED 2 0.0000
551 HOSPITALISATION 2 0.0000
552 PRURITUS 5 0.0000
553 DECREASED APPETITE 3 0.0000
554 FEELING ABNORMAL 3 0.0000
555 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
556 INFLUENZA LIKE ILLNESS 1 0.0000
557 CARDIAC ARREST 1 0.0000
558 ARTHRALGIA 5 0.0000
559 CEREBROVASCULAR ACCIDENT 2 0.0000
560 URINARY TRACT INFECTION 2 0.0000
561 RASH 5 0.0000
562 PRODUCT STORAGE ERROR 1 0.0000
563 TACHYCARDIA 1 0.0000
564 NO ADVERSE EVENT 2 0.0000
565 OROPHARYNGEAL PAIN 1 0.0000
566 DYSPNOEA 6 0.0000
567 DYSPHAGIA 1 0.0000
568 NEUROPATHY PERIPHERAL 1 0.0000
569 ATRIAL FIBRILLATION 1 0.0000
570 NAUSEA 8 0.0000
571 HEART RATE INCREASED 1 0.0000
572 HYPOTENSION 2 0.0000
573 HAEMOGLOBIN DECREASED 1 0.0000
574 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
575 CONSTIPATION 2 0.0000
576 INFLUENZA 1 0.0000
577 SEPSIS 1 0.0000
578 THROMBOCYTOPENIA 1 0.0000
579 SEIZURE 1 0.0000
580 ABDOMINAL PAIN 2 0.0000
581 DISEASE PROGRESSION 1 0.0000
582 HYPERHIDROSIS 1 0.0000
583 PRODUCT QUALITY ISSUE 1 0.0000
584 NEUTROPENIA 1 0.0000
585 VOMITING 3 0.0000
586 TREMOR 1 0.0000
587 MYALGIA 1 0.0000
588 BLOOD GLUCOSE INCREASED 1 0.0000
589 ANAEMIA 1 0.0000
590 ERYTHEMA 1 0.0000
591 INCORRECT DOSE ADMINISTERED 1 0.0000
592 INJECTION SITE PAIN 1 0.0000
593 DEATH 1 0.0000